Related Experiment Video
Updated: Jun 16, 2025

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation
Ketty Sinigaglia1, Anna Cherian1, Qiupei Du1
1Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia.
Abstract:
Adar null mutant mouse embryos die with aberrant double-stranded RNA (dsRNA)-driven interferon induction, and Adar Mavs double mutants, in which interferon induction is prevented, die soon after birth. Protein kinase R (Pkr) is aberrantly activated in Adar Mavs mouse pup intestines before death, intestinal crypt cells die, and intestinal villi are lost. Adar Mavs Eifak2 (Pkr) triple mutant mice rescue all defects and have long-term survival. Adenosine deaminase acting on RNA 1 (ADAR1) and PKR co-immunoprecipitate from cells, suggesting PKR inhibition by direct interaction. AlphaFold studies on an inhibitory PKR dsRNA binding domain (dsRBD)-kinase domain interaction before dsRNA binding and on an inhibitory ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA provide a testable model of the inhibition. Wild-type or editing-inactive human ADAR1 expressed in A549 cells inhibits activation of endogenous PKR. ADAR1 dsRNA binding is required for, but is not sufficient for, PKR inhibition. Mutating the ADAR1 dsRBD3-PKR contact prevents co-immunoprecipitation, ADAR1 inhibition of PKR activity, and co-localization of ADAR1 and PKR in cells.
Insights
Adenosine deaminase acting on RNA 1 (ADAR1) inhibits Protein Kinase R (PKR) activation, preventing embryonic lethality in mice. This interaction is crucial for maintaining intestinal integrity and long-term survival by regulating interferon responses.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Aberrant interferon induction leads to embryonic lethality in Adar null mutant mice.
- Mice lacking both Adar and Mavs exhibit early postnatal lethality, with intestinal damage linked to Protein Kinase R (PKR) activation.
Purpose of the Study:
- To investigate the protective role of Adenosine deaminase acting on RNA 1 (ADAR1) against PKR-mediated lethality.
- To elucidate the molecular mechanism of ADAR1-mediated PKR inhibition.
Main Methods:
- Generation and analysis of Adar, Mavs, and Eifak2 (PKR) mutant mouse models.
- Co-immunoprecipitation assays to detect protein interactions.
- AlphaFold structural modeling to predict binding interfaces.
- In vitro experiments using human ADAR1 in A549 cells to assess PKR activation.
Main Results:
- Triple mutant mice (Adar Mavs Eifak2) show rescued lethality and intestinal defects, indicating PKR's central role.
- ADAR1 and PKR co-immunoprecipitate, suggesting a direct interaction.
- Structural modeling proposes an inhibitory interaction between ADAR1's dsRBD3 and PKR's kinase domain.
- ADAR1 expression inhibits endogenous PKR activation in human cells, dependent on dsRNA binding and a specific ADAR1-PKR contact.
Conclusions:
- ADAR1 directly interacts with and inhibits PKR activation, preventing lethal interferon responses.
- The interaction requires ADAR1 dsRNA binding and a specific contact interface involving ADAR1 dsRBD3.
- This mechanism highlights ADAR1's critical role in innate immunity and preventing PKR-driven pathology.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response
RNA Editing
piRNA - Piwi-interacting RNAs

